Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's Sarepta Therapeutics Inc Holding Summary
As of 2023-09-30, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund held 916.00 shares of Sarepta Therapeutics Inc(SRPT), totaling $111,040.00. This investment constitutes 0.73% of their stock portfolio, and Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund now holds 0% of the outstanding Sarepta Therapeutics Inc(SRPT) stock.
The initial trade took place in 2019Q4. And since then Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund has made 4 purchases of SRPT, at an average price of $112.75, for a total of 2,212.00 shares. In addition, there have been 3 sales at an average price of $124.42 for 1,296.00 shares. Based on historical transaction data and SRPT's current price of $17.23, Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund's estimated gain on his SRPT holdings is $-72,368.34, reflecting a -29.02% gain to date.
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund SRPT ($17.23) Holding Chart
Touchstone Strategic Trust-Touchstone Anti-Benchmark US Core Equity Fund SRPT ($17.23) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
